Pin the accepted model and delivery identities, classify the proposed change, and require evidence proportional to its impact. Preserve historical outputs and decide rollout or withdrawal explicitly rather than accepting a new version through silent substitution.
Record the baseline that was actually accepted
Identify the model version, input definitions, configuration, output schema and delivery route covered by the original approval. Where the supplier does not disclose implementation details, agree an external version identifier and a change notice that provides enough information for the buyer's review. An unchanged product name is not sufficient evidence that the analytical behavior remains the same after an update.
NIST SP 800-128 addresses security-focused configuration management. Its baseline and controlled-change perspective is useful here, but it is not an investment-model validation standard. The buyer should define its own review requirements for analytical behavior alongside technical controls. Keep the two conclusions distinct so a successful software deployment does not become an unsupported statement that the revised model is appropriate for investment decisions.
- Pin analytical identity and delivery identity separately.
Classify changes by consequence
Distinguish documentation-only corrections, delivery changes, input substitutions and methodology changes. A field rename may be operationally breaking even if calculated values are unchanged. An upstream universe change may alter interpretation while preserving every field name. Ask the supplier to describe what changes, why, which historical outputs are affected and whether the buyer must take action before the new version arrives.
Define the review route before an urgent release. Minor editorial changes may need a document check; altered model logic may need independent research review and a new approval. The route should follow consequences, not the supplier's marketing label of minor or major. Record disagreements over classification so a lower-impact label cannot silently bypass the evidence the buyer needs.
- Classify by observed impact rather than release-name conventions.
Compare a fictional candidate with the frozen version
In a hypothetical fictional offer, the supplier provides a candidate update for a licensed research model and allows a side-by-side test. The buyer freezes 400 input records and compares outputs with the accepted version. Eighteen records differ, or 4.5% of the sample. Twelve changes match a documented identifier correction; six cannot yet be explained by the release note or the agreed tolerances.
The unexplained six represent 1.5% of all records, but their small share does not make them immaterial. Two concern the largest fictional positions in the test portfolio. The buyer pauses rollout and requests row-level explanations. This exercise tests change attribution, not future profitability, and the 400 records are software comparison fixtures rather than an independent strategy-validation sample.
- Investigate material unexplained changes even when aggregate differences are small.
| Fictional comparison | Records | Share of 400 |
|---|---|---|
| Unchanged | 382 | 95.5% |
| Explained changes | 12 | 3.0% |
| Unexplained changes | 6 | 1.5% |
| All changed records | 18 | 4.5% |
Separate software correctness from analytical evidence
A schema test can confirm valid types, required fields and identifier handling. A regression test can confirm that a known correction behaves as intended. Neither establishes whether a changed methodology has useful predictive properties. Ask the research owner what evidence is needed for that separate question and preserve the original evaluation criteria rather than rewriting them around whichever new outputs look most attractive.
Where the update changes assumptions rather than fixing a defect, document the affected use cases and limitations. The buyer may approve the technical transport while withholding analytical adoption. That split decision is more informative than a single green status covering unrelated claims. Do not imply that a supplier's backtest, an integration test and independently reviewed research are interchangeable forms of acceptance evidence.
- Keep technical regression results distinct from research validation.
Preserve revisions without rewriting history
Require correction records to identify what was originally published, what replaced it and when each version became available. The receiving workflow should distinguish a current corrected view from the information actually available at an earlier decision time. Overwriting every historical value may simplify a dashboard while destroying the evidence needed to explain past use and review a supplier's correction process.
Agree the retention and access arrangements for prior versions within the licence and applicable requirements. A promise to keep a change log is incomplete if that log disappears when the subscription ends. Define the permitted export format and the buyer's authorized archive. Do not assume the buyer receives source code, all training data or perpetual operational use merely because it needs a historical decision record.
- Retain original publication identity alongside any corrected view.
Make rollout and recovery explicit
Specify the proposed activation time, affected users, communication route and acceptance checks after delivery. Ask whether the old version can remain available during an agreed transition and what limits apply. A rollback plan should identify both the technical action and the decision authority. Returning to the old endpoint may be inadequate if the supplier has already changed its upstream data or removed historical dependencies.
For emergency changes, agree a bounded process that records the reason, immediate restrictions and required retrospective review. Urgency can justify a different sequence, but it should not erase accountability. If neither the old nor the candidate version is acceptable, the approved action may be to suspend the dependent workflow. Do not treat continued consumption as the automatic fallback when recovery is untested.
- Define who can activate, roll back or suspend consumption.
Close the change with a scoped decision
FINRA Regulatory Notice 21-29 discusses vendor change-management oversight for member firms. Applicability depends on the firm's activities; it does not impose the same process on every model buyer. Use the relevant internal governance route to record which reviewers accepted the candidate, which evidence they relied on and which restrictions remain. Link that decision to the released version rather than a generic supplier profile.
In the fictional example, rollout remains blocked until the six unexplained differences are resolved and the affected reviewers approve the outcome. A later pass preserves the first failed comparison and explains the repair. The final record should allow a new operator to reconstruct why this version was adopted without treating the example as a real client result or a claim about any actual model's performance.
- Retain failed comparisons and the evidence that resolved them.
Evaluation checkpoints
- An unchanged endpoint does not establish an unchanged model.
- Small unexplained differences can be material.
- Technical acceptance and analytical adoption require separate conclusions.
Source notes
Related questions
Make integration acceptance a reproducible test
Specify delivery fixtures, timestamps, replay behavior and acceptance evidence before a licensed model enters an operational workflow.
Write an approval record another reviewer can reconstruct
Record the exact licensed scope, evidence, budget, exceptions and authority behind a model procurement decision.
Make renewal a fresh evidence review
Review observed delivery, actual use, unresolved conditions and changed dependencies before renewing a model licence.
First edition, 16 October 2026. Illustrative procurement situations are not actual client engagements or legal advice.